SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-003201
Filing Date
2023-05-11
Accepted
2023-05-11 16:30:48
Documents
47
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xenetic_i10q-033123.htm   iXBRL 10-Q 421964
2 RESEARCH FUNDING AND OPTION AGREEMENT, DATED MARCH 17, 2023, BETWEEN THE COMPANY xenetic_ex1001.htm EX-10.1 139656
3 CERTIFICATION xenetic_ex3101.htm EX-31.1 10555
4 CERTIFICATION xenetic_ex3102.htm EX-31.2 10223
5 CERTIFICATION xenetic_ex3201.htm EX-32.1 5015
  Complete submission text file 0001683168-23-003201.txt   2472478

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE xbio-20230331.xsd EX-101.SCH 20797
7 XBRL CALCULATION FILE xbio-20230331_cal.xml EX-101.CAL 26374
8 XBRL DEFINITION FILE xbio-20230331_def.xml EX-101.DEF 105130
9 XBRL LABEL FILE xbio-20230331_lab.xml EX-101.LAB 162301
10 XBRL PRESENTATION FILE xbio-20230331_pre.xml EX-101.PRE 135261
41 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_i10q-033123_htm.xml XML 199616
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 23911548
SIC: 2834 Pharmaceutical Preparations